Showing results (341-350 of 358) with videos related to
Sort By:
Pageof 36
BMC Genomics|March 1, 2016
Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineagesJody E Phelan, Francesc Coll, Indra Bergval, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2025
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis TreatmentMarie Wijk, Paolo Denti, Kamunkhwala Gausi, et al.Journal of Bacteriology|January 13, 2009
African 1, an epidemiologically important clonal complex of Mycobacterium bovis dominant in Mali, Nigeria, Cameroon, and ChadBorna Müller, Markus Hilty, Stefan Berg, et al.Nature Microbiology|January 17, 2018
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosisLouis S Ates, Anzaan Dippenaar, Roy Ummels, et al.BMC Microbiology|March 8, 2006
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiologyKarine Brudey, Jeffrey R Driscoll, Leen Rigouts, et al.Frontiers in Immunology|June 9, 2020
Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosisZyanya Lucia Zatarain-Barrón, Octavio Ramos-Espinosa, Brenda Marquina-Castillo, et al.Genome Medicine|November 26, 2020
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment eraPatrick Beckert, Elisabeth Sanchez-Padilla, Matthias Merker, et al.The Lancet. Respiratory Medicine|January 23, 2017
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort studyKeertan Dheda, Jason D Limberis, Elize Pietersen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2020
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical ImplicationsBertin C Bisimwa, Jean B Nachega, Robin M Warren, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2019
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort StudyAndré N H Bulabula, Jenna A Nelson, Eric M Musafiri, et al.Pageof 36